Text Module


Share

Program Content

Activities

  • Role of the MDM2-p53 Pathway in BTC
    Targeting the MDM2-p53 Pathway in Biliary Tract Cancer: Emerging Data and Implications for Future Clinical Practice
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 29, 2024

    Expires: February 28, 2025

Faculty

cover img faculity

Patricia LoRusso, DO, PhD(h)

Associate Center Director, Experimental Therapeutics
Director, Early Phase Clinical Trials Program
Yale Cancer Center
Yale University
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.